Selank / Semax 10/10mg Blend

Two separate peptides supplied together in one vial at 10mg each. Selank is C33H57N11O9 at 751.9 g/mol, CAS 129954-34-3 (PubChem CID 11765600), sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Semax is C37H51N9O10S at 813.9 g/mol, CAS 80714-61-0 (PubChem CID 9811102), sequence Met-Glu-His-Phe-Pro-Gly-Pro. Oasis Labs supplies the blend as a lyophilized powder at 99%+ documented purity for laboratory research use only.

Packaging, not chemistry. The blend contains the same two compounds Oasis Labs lists individually, combined in a single vial at 10mg each rather than supplied as two separate items. It is SKU SEL-SEM-10-10MG. Each component retains its own molecular identity. No combined, additive or synergistic property is claimed or implied for the two together. Published research on each compound is specific to that compound. Both are supplied strictly as research reagents. No human or veterinary use is described, supported or intended.

Published research on each compound is separate. Selank is a tuftsin analogue, carrying the tuftsin tetrapeptide Thr-Lys-Pro-Arg extended by a C-terminal Pro-Gly-Pro; Semax corresponds to a fragment of adrenocorticotropic hormone extended by the same C-terminal Pro-Gly-Pro. Published in vitro and animal work has examined each peptide in receptor-binding and enzymatic-stability assay systems. Findings on one are not transferable to the other. Oasis Labs supplies this material strictly as a research reagent. No human or veterinary use is described, supported or intended.

SKU SEL-SEM-10-10MG. Supplied as a vial of lyophilized powder, white to off-white in appearance, at 99%+ documented purity by HPLC. Component identities: Selank, C33H57N11O9, 751.9 g/mol, CAS 129954-34-3, seven residues; and Semax, C37H51N9O10S, 813.9 g/mol, CAS 80714-61-0, seven residues. Lot documentation for this item is published on its Certificate of Analysis page.

Oasis Labs supplies the Selank and Semax blend direct to researchers from the USA, with fulfilment handled in Las Vegas, Nevada. Current pricing and bulk options are shown on the product page. Every lot is third-party tested and the Certificate of Analysis is published on the site and can be read in full before ordering. The COA is available at myoasislabs.com/coa/selank-semax-10mg-blend/ and the full testing methodology is documented at myoasislabs.com/coa-process/.

No. This product is sold FOR RESEARCH USE ONLY and is not for human or veterinary use, including medical, therapeutic or diagnostic applications. It is intended exclusively for in vitro laboratory research conducted by qualified professionals. It is not a drug, food, cosmetic, dietary supplement or medical device, and nothing on this page describes or recommends administration to humans or animals.

Yes. Every lot of Selank / Semax 10/10mg Blend from Oasis Labs Peptides is analyzed by independent, U.S.-based third-party laboratories using HPLC and mass spectrometry to confirm identity and purity against the label. Each batch is backed by a lot-specific Certificate of Analysis you can pull on demand. Selank / Semax 10/10mg Blend is supplied strictly for laboratory research use only.

Oasis Labs Peptides publishes a lot-level Certificate of Analysis for every batch of Selank / Semax 10/10mg Blend. You can look it up by product and lot in the COA library, where identity and purity are confirmed by independent U.S. third-party labs and matched to the production lot supplied. Selank / Semax 10/10mg Blend is supplied strictly for laboratory research use only.

Researchers choose Oasis Labs Peptides for Selank / Semax 10/10mg Blend because every batch is released against a documented purity specification, confirmed by HPLC and mass spectrometry, tested by domestic third-party labs rather than overseas certificates, and paired to a traceable production lot. It is offered strictly for research purposes only.